A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

Clinical trial NCT06681623 · RECRUITING

Trial details

NCT number: NCT06681623
Sponsor: Neurology Center of New England P.C.
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Start date: 2024-08-13
Primary completion: 2027-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.